- AboutOpenClose
- TeamOpenClose
- CareersOpenClose
- Investment FocusOpenClose
- Contract Services & Enabling TechnologiesOpenClose
- Biotech & MedtechOpenClose
- Antimicrobial ResistanceOpenClose
- FoundryOpenClose
- PortfolioOpenClose
- MediaOpenClose
Kincell Bio Announces New Board Chairman Mark R. Bamforth to Accelerate Company’s Growth and Expansion May 21st 2024 – Kincell Bio,…
EnteroBiotix Completes £27m Financing Round to Advance Clinical Trials, Initiates Phase 2 Study of EBX-102-02 in Patients with Irritable Bowl…
neuro42, a Kineticos Portfolio Company, Receives FDA Clearance on Portable and Compact Brain MRI Scanner for Point of Care Imaging…
Kineticos and INCATE join forces in supporting AMR innovators December 6th 2023 – INCATE (the INCubator for Antibacterial Therapies in…
Kineticos Life Sciences Announces Successful Final Close of approximately $60 Million for Kineticos Disruptor Fund II RALEIGH, N.C. | November…
Cell therapy CDMO spins out of Inceptor Bio to help innovators develop and manufacture life-saving cell therapies RALEIGH, N.C., AND…
New GMP facility to complete eXmoor’s transition from consultancy to one-stop global cell and gene therapy partner Bristol, UK |…
IMPuLSE Intestinal Microbiota Product in Liver Cirrhosis and Encephalopathy GLASGOW, United Kingdom | March 28, 2023 – EnteroBiotix Limited (“EBX”),…
Experic, a contract development and manufacturing organization (CDMO) and clinical supply services company serving the biopharmaceutical industry, today announced the…